Estimating treatment coverage for people with substance use disorders
| Autor(a) principal: | |
|---|---|
| Data de Publicação: | 2017 |
| Outros Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Tipo de documento: | Artigo |
| Idioma: | eng |
| Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
| Texto Completo: | http://hdl.handle.net/10362/151566 |
Resumo: | Funding: The authors are grateful to M. Kumvaj for her assistance with the systematic literature search. They also thank the staff of the WMHS Data Collection and Data Analysis Coordination Centres for assistance with instrumentation, fieldwork and consultation on data analysis. The WHO’s WMHS are supported by the US National Institute of Mental Health (R01 MH070884), the MacArthur Foundation, the Pfizer Foundation, the US Public Health Service (R13-MH066849, R01-MH069864 and R01 DA016558), the Fogarty International Center (R03-TW006481), the Pan American Health Organization, Eli Lilly and Company, Ortho-McNeil Pharmaceutical Inc., GlaxoSmithKline, Bristol-Myers Squibb, and Shire. The views expressed in this report are those of the authors and should not be construed to represent the views or policies of the WHO, other sponsoring organizations, agencies, or governments. This work was supported by an Australian National Health and Medical Research Council (NHMRC) project grant (no. 1081984). L. Degenhardt is supported by an NHMRC Principal Research Fellowship (no. 1041472). |
| id |
RCAP_67ea64d795502db1b0bfc8888ba6969c |
|---|---|
| oai_identifier_str |
oai:run.unl.pt:10362/151566 |
| network_acronym_str |
RCAP |
| network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
| repository_id_str |
7160 |
| spelling |
Estimating treatment coverage for people with substance use disordersan analysis of data from the World Mental Health SurveysalcoholdrugsSubstance use disorderstreatment coverageUnited Nations Sustainable Development GoalsWorld Health OrganizationPhychiatric Mental HealthPsychiatry and Mental healthSDG 3 - Good Health and Well-beingFunding: The authors are grateful to M. Kumvaj for her assistance with the systematic literature search. They also thank the staff of the WMHS Data Collection and Data Analysis Coordination Centres for assistance with instrumentation, fieldwork and consultation on data analysis. The WHO’s WMHS are supported by the US National Institute of Mental Health (R01 MH070884), the MacArthur Foundation, the Pfizer Foundation, the US Public Health Service (R13-MH066849, R01-MH069864 and R01 DA016558), the Fogarty International Center (R03-TW006481), the Pan American Health Organization, Eli Lilly and Company, Ortho-McNeil Pharmaceutical Inc., GlaxoSmithKline, Bristol-Myers Squibb, and Shire. The views expressed in this report are those of the authors and should not be construed to represent the views or policies of the WHO, other sponsoring organizations, agencies, or governments. This work was supported by an Australian National Health and Medical Research Council (NHMRC) project grant (no. 1081984). L. Degenhardt is supported by an NHMRC Principal Research Fellowship (no. 1041472).Substance use is a major cause of disability globally. This has been recognized in the recent United Nations Sustainable Development Goals (SDGs), in which treatment coverage for substance use disorders is identified as one of the indicators. There have been no estimates of this treatment coverage cross-nationally, making it difficult to know what is the baseline for that SDG target. Here we report data from the World Health Organization (WHO)'s World Mental Health Surveys (WMHS), based on representative community household surveys in 26 countries. We assessed the 12-month prevalence of substance use disorders (alcohol or drug abuse/dependence); the proportion of people with these disorders who were aware that they needed treatment and who wished to receive care; the proportion of those seeking care who received it; and the proportion of such treatment that met minimal standards for treatment quality (“minimally adequate treatment”). Among the 70,880 participants, 2.6% met 12-month criteria for substance use disorders; the prevalence was higher in upper-middle income (3.3%) than in high-income (2.6%) and low/lower-middle income (2.0%) countries. Overall, 39.1% of those with 12-month substance use disorders recognized a treatment need; this recognition was more common in high-income (43.1%) than in upper-middle (35.6%) and low/lower-middle income (31.5%) countries. Among those who recognized treatment need, 61.3% made at least one visit to a service provider, and 29.5% of the latter received minimally adequate treatment exposure (35.3% in high, 20.3% in upper-middle, and 8.6% in low/lower-middle income countries). Overall, only 7.1% of those with past-year substance use disorders received minimally adequate treatment: 10.3% in high income, 4.3% in upper-middle income and 1.0% in low/lower-middle income countries. These data suggest that only a small minority of people with substance use disorders receive even minimally adequate treatment. At least three barriers are involved: awareness/perceived treatment need, accessing treatment once a need is recognized, and compliance (on the part of both provider and client) to obtain adequate treatment. Various factors are likely to be involved in each of these three barriers, all of which need to be addressed to improve treatment coverage of substance use disorders. These data provide a baseline for the global monitoring of progress of treatment coverage for these disorders as an indicator within the SDGs.Centro de Estudos de Doenças Crónicas (CEDOC)NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)RUNDegenhardt, LouisaGlantz, Meyer D.Evans-Lacko, SaraSadikova, EkaterinaSampson, NancyThornicroft, GrahamAguilar-Gaxiola, SergioAl-Hamzawi, AliAlonso, JordiHelena Andrade, LauraBruffaerts, RonnyBunting, BrendanBromet, Evelyn J.de Girolamo, GiovanniFlorescu, SilviaGureje, OyeMaria Haro, JosepHuang, YueqinKaram, Aimee NasserKaram, Elie G.Kiejna, AndrzejLee, SingLepine, Jean PierreLevinson, DaphnaElena Medina-Mora, MariaNakamura, YosikazuNavarro-Mateu, FernandoPennell, Beth EllenPosada-Villa, JoséScott, Kate M.Stein, Dan J.ten Have, MargreetTorres, YolandaZarkov, ZahariChatterji, SomnathKessler, Ronald C.Adamowski, TomaszAguilar-Gaxiola, SergioAl-Hamzawi, AliAl-Kaisy, MohammadAlonso, JordiAltwaijri, YasminAndrade, Laura HelenaAtwoli, LukoyeAuerbach, Randy P.Axinn, William G.Benjet, CorinaBorges, GuilhermeCaldas-de-Almeida, José MCardoso, Graçaon behalf of the World Health Organization's World Mental Health Surveys collaborators2023-04-04T22:10:17Z2017-102017-10-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article9application/pdfhttp://hdl.handle.net/10362/151566eng1723-8617PURE: 3181606https://doi.org/10.1002/wps.20457info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:34:01Zoai:run.unl.pt:10362/151566Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:54:38.494108Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
| dc.title.none.fl_str_mv |
Estimating treatment coverage for people with substance use disorders an analysis of data from the World Mental Health Surveys |
| title |
Estimating treatment coverage for people with substance use disorders |
| spellingShingle |
Estimating treatment coverage for people with substance use disorders Degenhardt, Louisa alcohol drugs Substance use disorders treatment coverage United Nations Sustainable Development Goals World Health Organization Phychiatric Mental Health Psychiatry and Mental health SDG 3 - Good Health and Well-being |
| title_short |
Estimating treatment coverage for people with substance use disorders |
| title_full |
Estimating treatment coverage for people with substance use disorders |
| title_fullStr |
Estimating treatment coverage for people with substance use disorders |
| title_full_unstemmed |
Estimating treatment coverage for people with substance use disorders |
| title_sort |
Estimating treatment coverage for people with substance use disorders |
| author |
Degenhardt, Louisa |
| author_facet |
Degenhardt, Louisa Glantz, Meyer D. Evans-Lacko, Sara Sadikova, Ekaterina Sampson, Nancy Thornicroft, Graham Aguilar-Gaxiola, Sergio Al-Hamzawi, Ali Alonso, Jordi Helena Andrade, Laura Bruffaerts, Ronny Bunting, Brendan Bromet, Evelyn J. de Girolamo, Giovanni Florescu, Silvia Gureje, Oye Maria Haro, Josep Huang, Yueqin Karam, Aimee Nasser Karam, Elie G. Kiejna, Andrzej Lee, Sing Lepine, Jean Pierre Levinson, Daphna Elena Medina-Mora, Maria Nakamura, Yosikazu Navarro-Mateu, Fernando Pennell, Beth Ellen Posada-Villa, José Scott, Kate M. Stein, Dan J. ten Have, Margreet Torres, Yolanda Zarkov, Zahari Chatterji, Somnath Kessler, Ronald C. Adamowski, Tomasz Al-Kaisy, Mohammad Altwaijri, Yasmin Andrade, Laura Helena Atwoli, Lukoye Auerbach, Randy P. Axinn, William G. Benjet, Corina Borges, Guilherme Caldas-de-Almeida, José M Cardoso, Graça on behalf of the World Health Organization's World Mental Health Surveys collaborators |
| author_role |
author |
| author2 |
Glantz, Meyer D. Evans-Lacko, Sara Sadikova, Ekaterina Sampson, Nancy Thornicroft, Graham Aguilar-Gaxiola, Sergio Al-Hamzawi, Ali Alonso, Jordi Helena Andrade, Laura Bruffaerts, Ronny Bunting, Brendan Bromet, Evelyn J. de Girolamo, Giovanni Florescu, Silvia Gureje, Oye Maria Haro, Josep Huang, Yueqin Karam, Aimee Nasser Karam, Elie G. Kiejna, Andrzej Lee, Sing Lepine, Jean Pierre Levinson, Daphna Elena Medina-Mora, Maria Nakamura, Yosikazu Navarro-Mateu, Fernando Pennell, Beth Ellen Posada-Villa, José Scott, Kate M. Stein, Dan J. ten Have, Margreet Torres, Yolanda Zarkov, Zahari Chatterji, Somnath Kessler, Ronald C. Adamowski, Tomasz Al-Kaisy, Mohammad Altwaijri, Yasmin Andrade, Laura Helena Atwoli, Lukoye Auerbach, Randy P. Axinn, William G. Benjet, Corina Borges, Guilherme Caldas-de-Almeida, José M Cardoso, Graça on behalf of the World Health Organization's World Mental Health Surveys collaborators |
| author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
| dc.contributor.none.fl_str_mv |
Centro de Estudos de Doenças Crónicas (CEDOC) NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM) RUN |
| dc.contributor.author.fl_str_mv |
Degenhardt, Louisa Glantz, Meyer D. Evans-Lacko, Sara Sadikova, Ekaterina Sampson, Nancy Thornicroft, Graham Aguilar-Gaxiola, Sergio Al-Hamzawi, Ali Alonso, Jordi Helena Andrade, Laura Bruffaerts, Ronny Bunting, Brendan Bromet, Evelyn J. de Girolamo, Giovanni Florescu, Silvia Gureje, Oye Maria Haro, Josep Huang, Yueqin Karam, Aimee Nasser Karam, Elie G. Kiejna, Andrzej Lee, Sing Lepine, Jean Pierre Levinson, Daphna Elena Medina-Mora, Maria Nakamura, Yosikazu Navarro-Mateu, Fernando Pennell, Beth Ellen Posada-Villa, José Scott, Kate M. Stein, Dan J. ten Have, Margreet Torres, Yolanda Zarkov, Zahari Chatterji, Somnath Kessler, Ronald C. Adamowski, Tomasz Aguilar-Gaxiola, Sergio Al-Hamzawi, Ali Al-Kaisy, Mohammad Alonso, Jordi Altwaijri, Yasmin Andrade, Laura Helena Atwoli, Lukoye Auerbach, Randy P. Axinn, William G. Benjet, Corina Borges, Guilherme Caldas-de-Almeida, José M Cardoso, Graça on behalf of the World Health Organization's World Mental Health Surveys collaborators |
| dc.subject.por.fl_str_mv |
alcohol drugs Substance use disorders treatment coverage United Nations Sustainable Development Goals World Health Organization Phychiatric Mental Health Psychiatry and Mental health SDG 3 - Good Health and Well-being |
| topic |
alcohol drugs Substance use disorders treatment coverage United Nations Sustainable Development Goals World Health Organization Phychiatric Mental Health Psychiatry and Mental health SDG 3 - Good Health and Well-being |
| description |
Funding: The authors are grateful to M. Kumvaj for her assistance with the systematic literature search. They also thank the staff of the WMHS Data Collection and Data Analysis Coordination Centres for assistance with instrumentation, fieldwork and consultation on data analysis. The WHO’s WMHS are supported by the US National Institute of Mental Health (R01 MH070884), the MacArthur Foundation, the Pfizer Foundation, the US Public Health Service (R13-MH066849, R01-MH069864 and R01 DA016558), the Fogarty International Center (R03-TW006481), the Pan American Health Organization, Eli Lilly and Company, Ortho-McNeil Pharmaceutical Inc., GlaxoSmithKline, Bristol-Myers Squibb, and Shire. The views expressed in this report are those of the authors and should not be construed to represent the views or policies of the WHO, other sponsoring organizations, agencies, or governments. This work was supported by an Australian National Health and Medical Research Council (NHMRC) project grant (no. 1081984). L. Degenhardt is supported by an NHMRC Principal Research Fellowship (no. 1041472). |
| publishDate |
2017 |
| dc.date.none.fl_str_mv |
2017-10 2017-10-01T00:00:00Z 2023-04-04T22:10:17Z |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/151566 |
| url |
http://hdl.handle.net/10362/151566 |
| dc.language.iso.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
1723-8617 PURE: 3181606 https://doi.org/10.1002/wps.20457 |
| dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
9 application/pdf |
| dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
| instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
| instacron_str |
RCAAP |
| institution |
RCAAP |
| reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
| collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
| repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
| repository.mail.fl_str_mv |
|
| _version_ |
1799138135247945728 |